-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QgvomSpyk4+tthcfBOad4kOBHao2cGRZ5kRVSsLMn06M3A7N+eaMxCjtgFziN2Ig MNc8qnPGfaKf5rl30wkt0g== 0001104659-08-022100.txt : 20080402 0001104659-08-022100.hdr.sgml : 20080402 20080402164031 ACCESSION NUMBER: 0001104659-08-022100 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080331 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers FILED AS OF DATE: 20080402 DATE AS OF CHANGE: 20080402 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENOPTIX INC CENTRAL INDEX KEY: 0001138412 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 330840570 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33753 FILM NUMBER: 08734054 BUSINESS ADDRESS: STREET 1: 2110 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 760-268-6200 MAIL ADDRESS: STREET 1: 2110 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 8-K 1 a08-9858_18k.htm 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC  20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  March 31, 2008

 

GENOPTIX, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-33753

 

33-0840570

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(I.R.S. Employer Identification
 No.)

 

2110 Rutherford Road

Carlsbad, CA 92008

(Address of principal executive offices and zip code)

 

Registrant’s telephone number, including area code: (760) 268-6200

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 


 

Item 5.02.     Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On March 31, 2008, Stephen L. Spotts notified the Board of Directors of Genoptix, Inc., a Delaware corporation (“Genoptix”) of his decision not to stand for re-election at Genoptix’s 2008 annual meeting of stockholders due to other personal and business obligations.  Mr. Spotts will continue to serve a director of Genoptix until the 2008 annual meeting of stockholders, which is scheduled to be held on June 17, 2008.

 

2


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

GENOPTIX, INC.

 

 

 

 

Dated: April 2, 2008

By:

/s/ Christian V. Kuhlen

 

 

Christian V. Kuhlen, M.D., Esq.

 

 

Vice President, General Counsel

 

3

 -----END PRIVACY-ENHANCED MESSAGE-----